"We will continue to focus on a range of issues in relation to the PBS, of course, and important internal matters like governance, the Code of Conduct and listening to the membership - but our industry is also on the cusp of something quite extraordinary," says Vifor Pharma's James McDonnell.
James McDonnell: Industry 'on the cusp of something quite extraordinary'
September 20, 2019 Latest NewsBioPharmaDispatch Executive
Latest Video
New Stories
-
The 'Dispatched' Week in Review Podcast - 12 December
December 12, 2025 - - Podcast -
Medicines Australia gains a new voice with Vertex joining the association
December 11, 2025 - - Latest News -
BMS marks 70 years in Australia with renewed commitment to innovation and access
December 11, 2025 - - Latest News -
Opportunity cost is a moral and ethical question when it involves travel, tickets, or treating sick children
December 11, 2025 - - Latest News -
Pfizer’s high-stakes sprint to build momentum in century-defining market
December 11, 2025 - - Latest News -
Mayne Pharma rejects Cosette’s attempt to terminate scheme deal
December 10, 2025 - - Latest News -
TGA clears the way for LTR Pharma’s Phase 2 Study of SPONTAN
December 10, 2025 - - Australian Biotech
